Pesticide Exposure and Early Onset Colorectal Cancer

The condition is rising globally, with a reported 1.4% annual increase in incidence and a notable rise in younger populations relative to older groups.

Approximately one-fifth of cases occur in individuals under 55, and colorectal cancer has emerged as a leading cancer-related death in people under 50 in some settings.

The drivers of this trend remain incompletely understood.

• Early onset colorectal cancer is defined as diagnosis before age 50.

• The VHIO investigators explored the potential role of the exposome—the totality of lifetime environmental exposures—by examining epigenetic modifications rather than measuring exposures directly.
• The study centers on DNA methylation patterns as molecular footprints that reflect environmental influences on gene regulation without altering the DNA sequence.
• Epigenetic risk scores were constructed to represent exposure histories corresponding to dietary patterns, tobacco use, and environmental exposures, and these were assessed in colorectal cancer tissue from individuals diagnosed before versus after age 50.

data indicated that counties with higher picloram usage tended to have higher rates of early onset colorectal cancer, even after adjusting for socioeconomic variables and other pesticides.

• Distinct epigenetic signatures were identified that associated with diet, smoking, and environmental exposures in early onset cases.
• The team demonstrated that methylation-based signatures could be used to infer exposure history from tumor methylation data, providing a retrospective readout of environmental influence on tumor biology.
• A notable association emerged between early onset colorectal cancer and exposure to a widely used agricultural herbicide, picloram, alongside smoking and dietary factors.
• Population-level analysis using U.S.
• Tumors linked to higher picloram exposure exhibited distinct molecular characteristics, including fewer somatic variations in the APC gene, a key driver in colorectal carcinogenesis, suggesting that environmental exposures may influence tumor development through mechanisms beyond classical genetic mutations.

The work supports a link between certain environmental exposures—captured indirectly through epigenetic modifications—and early onset colorectal cancer, but does not prove that picloram, or any factor, directly causes disease.

• The authors emphasize that the reported associations do not establish causality.
• Further studies are required to corroborate causation, delineate mechanisms, and explore the generalizability of these epigenetic signatures across diverse populations and exposure contexts.
• The research leverages epigenetic data to reconstruct exposure histories, offering a framework for studying the exposome in relation to colorectal cancer without direct real-time exposure measurements.

• Epigenetic risk scoring may serve as a tool to interrogate environmental contributions to early onset colorectal cancer by reflecting integrated exposure histories within tumor tissue.
• The observed association with picloram suggests a potential area for further risk characterization and mechanistic investigation, though at present this remains an association pending causal confirmation.
• The study reinforces the importance of integrating environmental exposure assessment with molecular tumor profiling to understand cancer etiology, particularly in younger populations.

• It remains unclear whether picloram exposure directly drives early onset colorectal carcinogenesis or acts in concert with other factors.
• The strength and consistency of the epigenetic signatures across different populations and exposure landscapes require further validation.
• The precise biological mechanisms by which identified epigenetic changes translate to tumor initiation or progression were not definitively established in this work.

• Do the epigenetic footprints associated with picloram and other exposures predict risk independent of known risk factors?
• Could these methylation signatures be employed prospectively to identify individuals at elevated risk for early onset disease?
• What are the mechanistic pathways linking environmental exposures to the observed epigenetic alterations and to the reduced frequency of APC mutations in exposed tumors?

• Specific numerical values for incidence, effect sizes, or methylation loci are not provided in the summary.
• Direct causal experiments or longitudinal exposure assessments were not described in the provided material.